1. Participation at the Phase II Clinical Trial entitled “TPF chemotherapy in locally advanced resectable oral cavity squamous cell cancer in order to improve the rate of pathological complete response”, EORTC (European Organisation for Research and Treatment of Cancer) protocol number 24061. Coordinator, Dr.ssa Lisa Lecitra, Section for Medical Oncology and Head and Neck Tumours, Fondazione Istituto Nazionale Tumori, Milano. Responsible COMT members, Prof. Enrico Sesenna and Dr. Tito Poli.
   
   
2. Participation at the clinical study “Sentinel European Node Trial” (SENT; Sentinel Node Biopsy in the Management of Oral and Oropharyngeal Squamous Cell Carcinoma) supported by EORTC (European Organization for Research and Treatment of Cancer) and coordinated by Prof. Mark McGurk, Department of Oral and Maxillofacial Surgery, Guy’s Hospital, Londra, Gran Bretagna. Responsible COMT Member, Dr. Tito Poli

go to EORTC website